Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares Repurchased
Ratios

Haemonetics (HAE) Short-Term Debt issuances (2016 - 2020)

Historic Short-Term Debt issuances for Haemonetics (HAE) over the last 12 years, with Q4 2020 value amounting to -$150.0 million.

  • Haemonetics' Short-Term Debt issuances fell 310000.0% to -$150.0 million in Q4 2020 from the same period last year, while for Oct 2021 it was -$150.0 million, marking a year-over-year decrease of 23636.36%. This contributed to the annual value of -$60.0 million for FY2021, which is 23333.33% down from last year.
  • According to the latest figures from Q4 2020, Haemonetics' Short-Term Debt issuances is -$150.0 million, which was down 310000.0% from -$60.0 million recorded in Q3 2020.
  • In the past 5 years, Haemonetics' Short-Term Debt issuances ranged from a high of $150.0 million in Q2 2020 and a low of -$150.0 million during Q4 2020
  • Over the past 5 years, Haemonetics' median Short-Term Debt issuances value was $145000.0 (recorded in 2016), while the average stood at -$3.2 million.
  • Its Short-Term Debt issuances has fluctuated over the past 5 years, first plummeted by 1830045.66% in 2016, then surged by 1620434.78% in 2019.
  • Haemonetics' Short-Term Debt issuances (Quarter) stood at -$39.9 million in 2016, then surged by 100.41% to $162000.0 in 2017, then plummeted by 43.21% to $92000.0 in 2018, then surged by 5334.78% to $5.0 million in 2019, then plummeted by 3100.0% to -$150.0 million in 2020.
  • Its last three reported values are -$150.0 million in Q4 2020, -$60.0 million for Q3 2020, and $150.0 million during Q2 2020.